NASDAQ:VMD Viemed Healthcare (VMD) Stock Price, News & Analysis $7.42 +0.36 (+5.03%) As of 01:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Viemed Healthcare Stock (NASDAQ:VMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Viemed Healthcare alerts:Sign Up Key Stats Today's Range$7.09▼$7.4150-Day Range$6.53▼$7.9052-Week Range$6.21▼$9.81Volume106,831 shsAverage Volume139,205 shsMarket Capitalization$293.07 millionP/E Ratio27.46Dividend YieldN/APrice TargetN/AConsensus RatingStrong Buy Company OverviewViemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.Read More… Viemed Healthcare Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks35th Percentile Overall ScoreVMD MarketRank™: Viemed Healthcare scored higher than 35% of companies evaluated by MarketBeat, and ranked 899th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Viemed Healthcare.Read more about Viemed Healthcare's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Viemed Healthcare is 27.46, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.94.Price to Earnings Ratio vs. SectorThe P/E ratio of Viemed Healthcare is 27.46, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.74.Price to Book Value per Share RatioViemed Healthcare has a P/B Ratio of 2.51. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Viemed Healthcare's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.99% of the float of Viemed Healthcare has been sold short.Short Interest Ratio / Days to CoverViemed Healthcare has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Viemed Healthcare has recently decreased by 14.64%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldViemed Healthcare does not currently pay a dividend.Dividend GrowthViemed Healthcare does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.99% of the float of Viemed Healthcare has been sold short.Short Interest Ratio / Days to CoverViemed Healthcare has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Viemed Healthcare has recently decreased by 14.64%, indicating that investor sentiment is improving significantly. News and Social Media3.7 / 5News Sentiment1.60 News SentimentViemed Healthcare has a news sentiment score of 1.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.83 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Viemed Healthcare this week, compared to 1 article on an average week.Search Interest1 people have searched for VMD on MarketBeat in the last 30 days. Company Ownership2.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Viemed Healthcare insiders have not sold or bought any company stock.Percentage Held by Insiders20.00% of the stock of Viemed Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions74.24% of the stock of Viemed Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Viemed Healthcare's insider trading history. Receive VMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Viemed Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address VMD Stock News HeadlinesViemed Healthcare Announces First Quarter 2025 Earnings Conference Call DetailsApril 22, 2025 | globenewswire.comViemed Healthcare, Inc. (VMD): A Bull Case TheoryMarch 28, 2025 | insidermonkey.comWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."May 2, 2025 | Brownstone Research (Ad)Viemed Healthcare, Inc. (VMD) Q4 2024 Earnings Call TranscriptMarch 11, 2025 | seekingalpha.comViemed Healthcare Announces Record 2024 Financial ResultsMarch 10, 2025 | globenewswire.comViemed healthcare director Kaushal Nitin sells shares worth $571,200November 15, 2024 | investing.comViemed healthcare director sells shares worth $571,200November 15, 2024 | investing.comViemed Healthcare, Inc. (VMD) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comSee More Headlines VMD Stock Analysis - Frequently Asked Questions How have VMD shares performed this year? Viemed Healthcare's stock was trading at $8.02 at the beginning of 2025. Since then, VMD stock has decreased by 7.5% and is now trading at $7.4150. View the best growth stocks for 2025 here. How were Viemed Healthcare's earnings last quarter? Viemed Healthcare, Inc. (NASDAQ:VMD) issued its earnings results on Wednesday, November, 6th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.08 by $0.02. The firm had revenue of $58 million for the quarter. Viemed Healthcare had a trailing twelve-month return on equity of 8.72% and a net margin of 4.87%. Read the conference call transcript. Who are Viemed Healthcare's major shareholders? Viemed Healthcare's top institutional shareholders include Penbrook Management LLC (0.52%), Bank of New York Mellon Corp (0.20%), Violich Capital Management Inc. (0.05%) and Ulland Investment Advisors LLC (0.04%). Insiders that own company stock include Nitin Kaushal, Randy E Dobbs, Timothy Smokoff and Sabrina Heltz. View institutional ownership trends. How do I buy shares of Viemed Healthcare? Shares of VMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Viemed Healthcare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Viemed Healthcare investors own include Myomo (MYO), Cassava Sciences (SAVA), Alpha Teknova (TKNO), Heron Therapeutics (HRTX), Advanced Micro Devices (AMD), Zevra Therapeutics (ZVRA) and Enterprise Products Partners (EPD). Company Calendar Last Earnings11/06/2024Today5/02/2025Next Earnings (Estimated)5/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryHealthcare Current SymbolNASDAQ:VMD CIK1729149 Webwww.viemed.com Phone(337) 504-3802FaxN/AEmployees630Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.28 Trailing P/E Ratio27.46 Forward P/E RatioN/A P/E GrowthN/ANet Income$10.24 million Net Margins4.87% Pretax Margin6.97% Return on Equity8.72% Return on Assets6.48% Debt Debt-to-Equity Ratio0.03 Current Ratio1.31 Quick Ratio1.19 Sales & Book Value Annual Sales$224.26 million Price / Sales1.31 Cash Flow$0.78 per share Price / Cash Flow9.56 Book Value$2.96 per share Price / Book2.51Miscellaneous Outstanding Shares39,524,000Free Float31,150,000Market Cap$293.07 million OptionableNot Optionable Beta1.64 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:VMD) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viemed Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viemed Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.